Company: REVB
Filing Date: 2025-04-04
Form Type: DRS
Source: 0001213900-25-029022
Chunk: 77

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-04-04
Form: DRS
Chunk 77
---
” sections of this prospectus. The above discussion and table is based on 522,223shares of common stock outstanding on December 31, 2024, and excludes the following: •10,142shares of our common stock reserved for issuance under our 2021 Equity Incentive Plan; •3shares of our common stock reserved for the issuance of Rollover RSUs; •64shares issuable upon exercise of stock options outstanding under our 2021 Equity Incentive Plan; •7shares of our common stock reserved for the issuance of Rollover Warrants, with an exercise price of $45,070.73 per share; •176shares of our common stock issuable upon the exercise of the Class A Common Stock Warrants, with an exercise price of $55,272.00 per share; •497shares of our common stock issuable upon the exercise of the Class B Common Stock Warrants, with an exercise price of $10,080.00 per share; •35shares of our common stock issuable upon the exercise of the Class B Placement Agent Warrants, with an exercise price of $12,600.00 per share; •194shares of our common stock issuable upon the alternative cashless exercise of the Class C Common Stock Warrants, or 485shares of our common stock upon cash exercise with an exercise price of $16.00 per share; •5,060shares of common stock issuable upon the exercise of the Class D Common Stock Warrants, with an exercise price of $3.85 per share; •64,506shares of common stock issuable upon the exercise of the Class E Common Stock Warrants, with an exercise price of $16.00 per share;

45 •508,006shares of our common stock issuable upon the alternative cashless exercise of the Class F Common Stock Warrants, or 254,003shares of our common stock upon cash exercise with an exercise price of $16.00 per share; •381,004shares of common stock issuable upon the exercise of the Class G Common Stock Warrants, with an exercise price of $3.76 per share; and •shares of common stock issuable upon the exercise of the Common Stock Warrants issued pursuant to this offering. 46

DILUTION If you invest in our securities in this offering, your interest will be diluted to the extent of the difference between the public offering price per share of common stock and accompanying Common Stock Warrants and the pro forma as adjusted net